Your browser doesn't support javascript.
loading
Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells.
Tangeda, Vidhya; Lo, Yu Kang; Babuharisankar, Ananth Ponneri; Chou, Han-Yu; Kuo, Cheng-Liang; Kao, Yung-Hsi; Lee, Alan Yueh-Luen; Chang, Jang-Yang.
Affiliation
  • Tangeda V; Joint PhD program in molecular medicine, National Central University & National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
  • Lo YK; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
  • Babuharisankar AP; Department of Life Sciences, College of Health Sciences & Technology, National Central University, Taoyuan, Zhongli, 32001, Taiwan.
  • Chou HY; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
  • Kuo CL; Joint PhD program in molecular medicine, National Central University & National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
  • Kao YH; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
  • Lee AY; Department of Life Sciences, College of Health Sciences & Technology, National Central University, Taoyuan, Zhongli, 32001, Taiwan.
  • Chang JY; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
Cell Death Dis ; 13(3): 241, 2022 03 16.
Article in En | MEDLINE | ID: mdl-35296653

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Death Dis Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Death Dis Year: 2022 Document type: Article Affiliation country: Country of publication: